Eve‐Irene Lepist

1.5k total citations
22 papers, 975 citations indexed

About

Eve‐Irene Lepist is a scholar working on Oncology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eve‐Irene Lepist has authored 22 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Infectious Diseases and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eve‐Irene Lepist's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (6 papers) and HIV/AIDS drug development and treatment (5 papers). Eve‐Irene Lepist is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (6 papers) and HIV/AIDS drug development and treatment (5 papers). Eve‐Irene Lepist collaborates with scholars based in United States, Estonia and Sweden. Eve‐Irene Lepist's co-authors include Adrian S. Ray, Hao Jia, Bernard P. Murray, Gabriel Birkuš, Tomáš Cihlář, Darius Babusis, Yeojin Park, Eisuke Murakami, Ting Wang and William J. Jusko and has published in prestigious journals such as PLoS ONE, Kidney International and Journal of Medicinal Chemistry.

In The Last Decade

Eve‐Irene Lepist

22 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eve‐Irene Lepist United States 16 324 278 199 186 169 22 975
Mary Beth Wire United States 18 325 1.0× 186 0.7× 144 0.7× 83 0.4× 289 1.7× 36 957
Elizabeth K. Hussey United States 19 295 0.9× 104 0.4× 108 0.5× 247 1.3× 224 1.3× 39 983
Barry Quart United States 15 232 0.7× 109 0.4× 55 0.3× 331 1.8× 77 0.5× 28 1.2k
Michael Kukulka United States 14 256 0.8× 157 0.6× 83 0.4× 94 0.5× 48 0.3× 28 802
Julia Blievernicht Germany 10 365 1.1× 510 1.8× 170 0.9× 230 1.2× 89 0.5× 10 1.3k
Gary D. Bowers United States 15 170 0.5× 174 0.6× 93 0.5× 188 1.0× 85 0.5× 24 620
Niresh Hariparsad United States 18 189 0.6× 355 1.3× 194 1.0× 194 1.0× 65 0.4× 37 974
Tanja Saußele Germany 9 454 1.4× 316 1.1× 178 0.9× 176 0.9× 91 0.5× 13 1.1k
J H Lin United States 13 209 0.6× 325 1.2× 140 0.7× 146 0.8× 76 0.4× 17 769
Janet R. Wade United States 19 129 0.4× 191 0.7× 200 1.0× 116 0.6× 156 0.9× 37 1.0k

Countries citing papers authored by Eve‐Irene Lepist

Since Specialization
Citations

This map shows the geographic impact of Eve‐Irene Lepist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eve‐Irene Lepist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eve‐Irene Lepist more than expected).

Fields of papers citing papers by Eve‐Irene Lepist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eve‐Irene Lepist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eve‐Irene Lepist. The network helps show where Eve‐Irene Lepist may publish in the future.

Co-authorship network of co-authors of Eve‐Irene Lepist

This figure shows the co-authorship network connecting the top 25 collaborators of Eve‐Irene Lepist. A scholar is included among the top collaborators of Eve‐Irene Lepist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eve‐Irene Lepist. Eve‐Irene Lepist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chandrasekhar, Jayaraman, Ryan A. Dick, David Koditek, et al.. (2018). Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor. Journal of Medicinal Chemistry. 61(15). 6858–6868. 48 indexed citations
2.
3.
Lepist, Eve‐Irene & Adrian S. Ray. (2017). Beyond drug-drug interactions: effects of transporter inhibition on endobiotics, nutrients and toxins. Expert Opinion on Drug Metabolism & Toxicology. 13(10). 1075–1087. 21 indexed citations
4.
Giacomini, Marilyn M., Hao Jia, Xiaomin Liang, et al.. (2016). Interaction of 2,4-Diaminopyrimidine–Containing Drugs Including Fedratinib and Trimethoprim with Thiamine Transporters. Drug Metabolism and Disposition. 45(1). 76–85. 29 indexed citations
5.
Lepist, Eve‐Irene & Adrian S. Ray. (2016). Renal Transporter‐Mediated Drug‐Drug Interactions: Are They Clinically Relevant?. The Journal of Clinical Pharmacology. 56(S7). S73–81. 29 indexed citations
6.
Murakami, Eisuke, Ting Wang, Yeojin Park, et al.. (2015). Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy. Antimicrobial Agents and Chemotherapy. 59(6). 3563–3569. 132 indexed citations
7.
Liang, Xiaomin, Huan‐Chieh Chien, Sook Wah Yee, et al.. (2015). Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3). Molecular Pharmaceutics. 12(12). 4301–4310. 82 indexed citations
8.
Lepist, Eve‐Irene, Xuexiang Zhang, Hao Jia, et al.. (2014). Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat. Kidney International. 86(2). 350–357. 190 indexed citations
9.
10.
Stray, Kirsten M., Rujuta A. Bam, Gabriel Birkuš, et al.. (2013). Evaluation of the Effect of Cobicistat on theIn VitroRenal Transport and Cytotoxicity Potential of Tenofovir. Antimicrobial Agents and Chemotherapy. 57(10). 4982–4989. 39 indexed citations
11.
Lepist, Eve‐Irene, Vijaya L. Damaraju, Jing Zhang, et al.. (2013). Transport of A1 Adenosine Receptor Agonist Tecadenoson by Human and Mouse Nucleoside Transporters: Evidence for Blood-Brain Barrier Transport by Murine Equilibrative Nucleoside Transporter 1 mENT1. Drug Metabolism and Disposition. 41(4). 916–922. 9 indexed citations
12.
Custodio, Joseph M., Hui Wang, Hao Jia, et al.. (2013). Pharmacokinetics of cobicistat boosted‐elvitegravir administered in combination with rosuvastatin. The Journal of Clinical Pharmacology. 54(6). 649–656. 30 indexed citations
13.
Sukumaran, Siddharth, Eve‐Irene Lepist, Debra C. DuBois, Richard R. Almon, & William J. Jusko. (2012). Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone Effects on iNOS mRNA Expression and Nitric Oxide During LPS-Induced Inflammation in Rats. Pharmaceutical Research. 29(8). 2060–2069. 12 indexed citations
14.
Lepist, Eve‐Irene, et al.. (2012). Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340, In Vitro. Antimicrobial Agents and Chemotherapy. 56(10). 5409–5413. 110 indexed citations
15.
Lepist, Eve‐Irene & Adrian S. Ray. (2012). Renal drug–drug interactions: what we have learned and where we are going. Expert Opinion on Drug Metabolism & Toxicology. 8(4). 433–448. 50 indexed citations
16.
Lepist, Eve‐Irene & William J. Jusko. (2004). Modeling and allometric scaling of s(+)‐ketoprofen pharmacokinetics and pharmacodynamics: a retrospective analysis. Journal of Veterinary Pharmacology and Therapeutics. 27(4). 211–218. 33 indexed citations
17.
Gordi, Toufigh & Eve‐Irene Lepist. (2004). Response to the Letter to the Editor by Stephen Toovey and Andrew Jamieson. Toxicology Letters. 151(3). 491–492. 2 indexed citations
18.
Lepist, Eve‐Irene, Sven Frøkjær, Mitchell E. Taub, et al.. (2000). Stability and in vitro metabolism of dipeptide model prodrugs with affinity for the oligopeptide transporter. European Journal of Pharmaceutical Sciences. 11(1). 43–50. 15 indexed citations
19.
Lepist, Eve‐Irene, et al.. (1999). Stability and perfusion studies of Desmopressin (dDAVP) and prodrugs in the rat jejunum. Experimental and Toxicologic Pathology. 51(4-5). 363–368. 3 indexed citations
20.
Steffansen, Bente, Eve‐Irene Lepist, Mitchell E. Taub, et al.. (1999). Stability, metabolism and transport of d-Asp(OBzl)–Ala — a model prodrug with affinity for the oligopeptide transporter. European Journal of Pharmaceutical Sciences. 8(1). 67–73. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Beth Wire Breakdown of academic impact, for papers by Elizabeth K. Hussey Breakdown of academic impact, for papers by Barry Quart Breakdown of academic impact, for papers by Michael Kukulka Breakdown of academic impact, for papers by Julia Blievernicht Breakdown of academic impact, for papers by Gary D. Bowers Breakdown of academic impact, for papers by Niresh Hariparsad Breakdown of academic impact, for papers by Tanja Saußele Breakdown of academic impact, for papers by J H Lin Breakdown of academic impact, for papers by Janet R. Wade
Rankless by CCL
2026